The antidiabetic effect of superparamagnetic iron oxide nanoparticles highlights the role of WNT/AMPK/mTOR/FOXO1/mitochondrial DNA in muscle and kidney

Nanomedicine (Lond). 2023 Feb;18(5):417-435. doi: 10.2217/nnm-2022-0136. Epub 2023 May 11.

Abstract

Aim: To explore the antidiabetic effect of superparamagnetic iron oxide nanoparticles (SPIONs)-PEG-550 and its related metabolic pathways in muscles and kidney. Materials & methods: Diabetes was induced in 5-day neonatal rats; after confirming diabetes, treatment with SPIONs-PEG-550 started at different doses for 4 weeks. Routine analysis of glucose, insulin, adipocytokines, urea and creatinine was performed. The expression of several genes involved in metabolic pathways and the corresponding protein levels were examined. Results & conclusion: SPIONs-PEG-550 normalized the disturbed glucose homeostasis, reversed insulin resistance, adjusted the serum level of adipocytokines, and improved several disturbed downstream effectors of the insulin signaling and WNT pathway in both tissues. Histological examination of the muscle and pancreas has shown almost normal functional characteristics without remarkable adverse effects on the kidney.

Keywords: SPIONs; Type 2 diabetes; WNT pathway; insulin resistance; mtDNA; superparamagnetic iron oxide nanoparticles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases
  • Animals
  • DNA, Mitochondrial
  • Forkhead Box Protein O1
  • Glucose
  • Hypoglycemic Agents*
  • Insulin
  • Kidney
  • Magnetic Iron Oxide Nanoparticles
  • Magnetite Nanoparticles*
  • Muscles
  • Rats
  • TOR Serine-Threonine Kinases

Substances

  • Hypoglycemic Agents
  • Magnetite Nanoparticles
  • AMP-Activated Protein Kinases
  • DNA, Mitochondrial
  • Glucose
  • Insulin
  • TOR Serine-Threonine Kinases
  • Foxo1 protein, rat
  • Forkhead Box Protein O1
  • mTOR protein, rat